NASDAQ (usa) arrow 6715.56 -12.11 -0.18%
FTSE 100 (london) arrow 7487.96 -5.12 -0.07%
DAX (german) arrow 13465.51 235.94 1.78%
NIKKEI 225 (japan) arrow 22420.08 408.47 1.86%
Hang - Seng (hong kong) arrow 28594.06 348.52 1.23%
NIFTY - 50 (india)
Straits Times (singapore) arrow 3391.61 17.53 0.52%
KOSPI (korea) arrow 2556.47 33.04 1.31%
All Ordinaries (australia) arrow 6005.30 28.90 0.48%
BOVESPA (brazil) arrow 74092.76 -215.73 -0.29%

Abbott Laboratories (NYSE: ABT)

ABT Technical Analysis
As on 26th Nov 2021 ABT Share Price closed @ 125.88 and we RECOMMEND Strong Buy for LONG-TERM with Stoploss of 116.01 & Strong Buy for SHORT-TERM with Stoploss of 108.76 we also expect STOCK to react on Following IMPORTANT LEVELS.

ABT Share Price

Open 127.81 Change Price %
High 129.71 1 Day 0.81 0.65
Low 125.44 1 Week -5.01 -3.83
Close 125.88 1 Month 8.31 7.07
Volume 4671350 1 Year 19.38 18.20
52 Week High 130.89 | 52 Week Low 105.00
NYSE USA Most Active Stocks
DDR 15.44 -4.46%
BACA-U 302.00 0.67%
CCL 17.95 -10.96%
PFE 54.00 6.11%
BAC 45.76 -3.93%
RPAI 13.15 -3.17%
F 19.75 -2.47%
RLX 5.51 1.85%
NCLH 20.06 -11.36%
DAL 36.38 -8.34%
NYSE USA Top Gainers Stocks
EBR-B 5.77 454.81%
CARS 16.12 21.11%
CARS 16.12 21.11%
CARS 16.12 21.11%
STEM-WT 14.40 17.74%
CZZ 0.17 13.33%
CZZ 0.17 13.33%
BKSY-WS 1.30 9.24%
CNF 4.95 8.55%
CNF 4.95 8.55%
NYSE USA Top Losers Stocks
KWAC-WS 0.61 -93.97%
NSH-WS 14.00 -92.00%
NSH 14.00 -92.00%
NSH 14.00 -92.00%
NSH 14.00 -92.00%
NSH-U 14.00 -92.00%
MTEST 20.00 -20.16%
OIBR-C 0.72 -20.00%
FRX-WS 0.04 -20.00%
FRX-U 0.04 -20.00%
Daily Charts
Intraday Charts
Whats New @
Free Analysis
ABT Important Levels Intraday
ABT Target for Month November
4th UP TARGET143.8
3rd UP TARGET138.05
2nd UP TARGET134.5
1st UP TARGET130.95
1st DOWN TARGET120.81
2nd DOWN TARGET117.26
3rd DOWN TARGET113.71
4th DOWN TARGET107.96
ABT Weekly Target
4th UP TARGET136.52
3rd UP TARGET133.11
2nd UP TARGET131.00
1st UP TARGET128.89
1st DOWN TARGET122.87
2nd DOWN TARGET120.76
3rd DOWN TARGET118.65
4th DOWN TARGET115.24
ABT Target for Year 2021
4th UP TARGET180.74
3rd UP TARGET163.15
2nd UP TARGET152.27
1st UP TARGET141.4
1st DOWN TARGET110.36
2nd DOWN TARGET99.49
3rd DOWN TARGET88.61
4th DOWN TARGET71.02
ABT Other Details
Segment EQ
Market Capital 228339220480.00
Sector Healthcare
Industry Medical Devices
Offical website >
ABT Address
ABT Latest News
Your Comments and Response on Abbott Laboratories
ABT Business Profile
Abbott Laboratories discovers, develops, manufactures, and sells health care products worldwide. It operates in four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The Established Pharmaceutical Products segment provides generic pharmaceuticals for the treatment of pancreatic exocrine insufficiency, irritable bowel syndrome or biliary spasm, intrahepatic cholestasis or depressive symptoms, gynecological disorder, hormone replacement therapy, dyslipidemia, hypertension, hypothyroidism, Ménière's disease and vestibular vertigo, pain, fever, inflammation, and migraine, as well as provides anti-infective clarithromycin, influenza vaccine, and products to regulate physiological rhythm of the colon. The Diagnostic Products segment offers laboratory systems in the areas of immunoassay, clinical chemistry, hematology, and transfusion; molecular diagnostics systems that automate the extraction, purification, and preparation of DNA and RNA from patient samples, as well as detect and measure infectious agents; point of care systems; cartridges for testing blood; rapid diagnostics lateral flow testing products; molecular point-of-care testing for HIV, SARS-CoV-2, influenza A and B, RSV, and strep A; cardiometabolic test systems; drug and alcohol test, and remote patient monitoring and consumer self-test systems; and informatics and automation solutions for use in laboratories. The Nutritional Products segment provides pediatric and adult nutritional products. The Medical Devices segment offers rhythm management, electrophysiology, heart failure, vascular, and structural heart devices for the treatment of cardiovascular diseases; and diabetes care products, as well as neuromodulation devices for the management of chronic pain and movement disorders. It has collaboration agreement with Cereno Scientific AB (publ). The company was founded in 1888 and is based in North Chicago, Illinois. Address: 100 Abbott Park Road, North Chicago, IL, United States, 60064-6400
2005-2021 All rights reserved.

Data and information is provided for informational purposes only, and is not intended for trading purposes.
Neither website nor any of its promoters shall be liable for any errors
or delays in the content, or for any actions taken in reliance thereon. Your use of this website constitutes
acceptance of our Terms Of Service